Virax Biolabs Group (VRAX) Short Interest Ratio & Short Volume → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free VRAX Stock Alerts $0.70 +0.04 (+5.49%) (As of 02:46 PM ET) Add Compare Share Share Short InterestStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Virax Biolabs Group Short Interest DataCurrent Short Volume12,000 sharesPrevious Short Volume3,000 sharesChange Vs. Previous Month+300.00%Dollar Volume Sold Short$8,100.00Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares1,550,000 sharesFloat Size1,730,000 sharesShort Percent of Float0.69%Today's Trading Volume7,588 sharesAverage Trading Volume77,060 sharesToday's Volume Vs. Average10% Short Selling Virax Biolabs Group ? Sign up to receive the latest short interest report for Virax Biolabs Group and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVRAX Short Interest Over TimeVRAX Days to Cover Over TimeVRAX Percentage of Float Shorted Over Time Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… Virax Biolabs Group Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202412,000 shares $8,100.00 +300.0%0.7%0.2 $0.68 3/31/20243,000 shares $2,151.00 -80.9%0.2%0 $0.72 3/15/202415,700 shares $13,277.49 -74.1%1.2%0.1 $0.85 2/29/202460,600 shares $58,327.50 +9.2%4.6%0.4 $0.96 2/15/202455,500 shares $45,626.55 -44.8%4.2%0.4 $0.82 1/31/2024100,500 shares $82,410.00 +233.9%8.5%0.8 $0.82 Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 1/15/202430,100 shares $31,003.00 -78.3%2.6%0.4 $1.03 12/31/2023138,600 shares $202,356.00 +6,500.0%7.7%1.9 $1.46 12/15/20232,100 shares $3,334.80 -93.1%0.0%0 $1.59 11/30/202330,200 shares $7,021.50 -39.8%0.3%0.2 $0.23 11/15/202350,200 shares $12,750.80 -30.4%0.5%0.3 $0.25 10/31/202372,100 shares $17,686.13 -24.7%0.8%0.4 $0.25 10/15/202395,700 shares $28,327.20 -24.1%1.0%0.6 $0.30 9/30/2023126,000 shares $40,950.00 -32.9%1.4%0.7 $0.33 9/15/2023187,800 shares $67,889.70 +476.1%2.0%1.1 $0.36 8/31/202332,600 shares $11,670.80 +565.3%0.4%0.1 $0.36 8/15/20234,900 shares $1,888.95 -80.3%0.1%0 $0.39 7/31/202324,900 shares $9,820.56 -48.2%0.3%0.1 $0.39 7/15/202348,100 shares $19,196.71 -68.9%0.5%0.2 $0.40 6/30/2023154,400 shares $60,200.56 -46.2%1.7%0.3 $0.39 6/15/2023286,700 shares $117,202.96 +42.2%3.1%0.5 $0.41 5/31/2023201,600 shares $78,966.72 +0.6%3.2%0.4 $0.39 5/15/2023200,500 shares $70,395.55 No Change3.1%0.1 $0.35 VRAX Short Interest - Frequently Asked Questions What is Virax Biolabs Group's current short interest? Short interest is the volume of Virax Biolabs Group shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 3,000 shares of VRAX short. 0.17% of Virax Biolabs Group's shares are currently sold short. Learn More on Virax Biolabs Group's current short interest. What is a good short interest percentage for Virax Biolabs Group? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.17% of Virax Biolabs Group's floating shares are currently sold short. Is Virax Biolabs Group's short interest increasing or decreasing? Virax Biolabs Group saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 3,000 shares, a drop of 80.9% from the previous total of 15,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Virax Biolabs Group's float size? Virax Biolabs Group currently has issued a total of 1,550,000 shares. Some of Virax Biolabs Group's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virax Biolabs Group currently has a public float of 1,730,000 shares. How does Virax Biolabs Group's short interest compare to its competitors? 0.17% of Virax Biolabs Group's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Virax Biolabs Group: Biodexa Pharmaceuticals Plc (5.18%), TC Biopharm (Holdings) Plc (30.07%), Scinai Immunotherapeutics Ltd. (0.29%), SciSparc Ltd. (24.15%), Bone Biologics Co. (3.07%), Sunshine Biopharma, Inc. (0.77%), Invitae Co. (26.15%), Acorda Therapeutics, Inc. (0.66%), Akanda Corp. (0.03%), Sintx Technologies, Inc. (5.38%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Virax Biolabs Group stock? Short selling VRAX is an investing strategy that aims to generate trading profit from Virax Biolabs Group as its price is falling. VRAX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virax Biolabs Group? A short squeeze for Virax Biolabs Group occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRAX, which in turn drives the price of the stock up even further. How often is Virax Biolabs Group's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRAX, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: BDRX Short Interest TCBP Short Interest SCNI Short Interest SPRC Short Interest BBLG Short Interest SBFM Short Interest NVTA Short Interest ACOR Short Interest AKAN Short Interest SINT Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRAX) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe A.I. story nobody is telling you (Read ASAP)TradeSmithRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyYour Money is Not SafeAmerican Alternative